QuidelOrtho Corp. Aktie
QuidelOrtho Corp. Aktie
Was spricht für und gegen QuidelOrtho Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von QuidelOrtho Corp. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
QuidelOrtho Corp. | 0,49 % | 2,48 % | 8,95 % | -47,85 % | -38,96 % | -57,46 % | - |
Boston Scientific | -0,72 % | 0,00 % | 6,98 % | 39,37 % | 34,14 % | 101,70 % | 104,60 % |
Waters Corp. | -0,03 % | 6,69 % | 10,38 % | 32,76 % | 9,90 % | 31,71 % | 76,22 % |
Illumina Inc. | -1,97 % | 2,77 % | -4,93 % | -43,35 % | -18,04 % | -66,46 % | -62,14 % |
Kommentare
News
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ
QuidelOrtho Corporation (Nasdaq: QDEL) has launched a second state-of-the-art United States distribution center in Pedricktown, New Jersey. This strategic endeavor epitomizes QuidelOrtho’s
QuidelOrtho Reports First Quarter 2024 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and
QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point of care settings, clinical labs and